Life Science Partnering
This group will provide life science partnering news and information on events, sectors and topics of interest here on partnering360. Look for upcoming features and discussions intended to maximize your partnering experience.
How can you better manage your personal schedule and your meeting schedule at the same time? At EBD Group events, we have created new features for partneringONE® that will improve your experience and increase the number of meeting requests you can make. Read more: http://bit.ly/1NBCJib
An award ceremony to honor the recipient of the Nanomedicine Award will take place during BIO-Europe® 2015 in Munich, Germany, on November 3, 2015. Award nominations are accepted for projects focused on totally novel diagnostic and therapeutic approaches that address unmet medical needs using nanomedicine. Entries for nominations for the Award will be open until September 15, 2015. For more information, go to http://bit.ly/1UoKo4g
BioMedTracker's drug development Outlook Report for 3Q 2015 has just been released with their list of large-impact catalysts. This quarter’s list includes over 20 highlights plus a few medtech entries and a catalyst calendar. How do reports like this change your drug development partnering strategy at partnering events such as BioPharm America? Read the post on partnering360® Blog> http://bit.ly/1D8JOmK
Johnson &Johnson Innovation is a trend setter because of their biotech investment model and approach as a community-based hub focused on discovery, community and knowing where innovation happens. Why do you think it works and how can we make it better?
Read more on #p360Blog> http://bit.ly/1LyzRlr
According to The Life Sciences Report Small-Cap Biotech Watchlist, catalysts move stock prices and some catalysts move stocks more than others.
Read today's guest post by Jim Patrick, publisher, The Life Sciences Report called "What to Look for in Companies Navigating Drug Approval Processes on Both Sides of the Pond" at http://bit.ly/1Egu4gT. And share your opinion here.